These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 31710239)

  • 1. Synthesis and vasodilator activity of some pyridazin-3(2
    Allam HA; Kamel AA; El-Daly M; George RF
    Future Med Chem; 2020 Jan; 12(1):37-50. PubMed ID: 31710239
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthesis, vasorelaxant activity and 2D-QSAR study of some novel pyridazine derivatives.
    George RF; Saleh DO
    Eur J Med Chem; 2016 Jan; 108():663-673. PubMed ID: 26735908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, Molecular Modeling of Novel Substituted Pyridazinones and their Vasorelaxant Activities.
    Ismail MMF; Soliman DHS; Elmoniem MHA; Jaleel GAA
    Med Chem; 2021; 17(2):171-186. PubMed ID: 32216740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and vasodilatory activity of some amide derivatives of 6-(4-carboxymethyloxyphenyl)-4,5-dihydro-3(2H)-pyridazinone.
    Bansal R; Kumar D; Carron R; de la Calle C
    Eur J Med Chem; 2009 Nov; 44(11):4441-7. PubMed ID: 19589624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Some pyridazinone and phthalazinone derivatives and their vasodilator activities.
    Demirayak S; Karaburun AC; Kayagil I; Erol K; Sirmagul B
    Arch Pharm Res; 2004 Jan; 27(1):13-8. PubMed ID: 14969331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and evaluation of 2-substituted-6-phenyl-4,5-dihydropyridazin-3(2H)-ones as potent inodilators.
    Kumar D; Carron R; La Calle CD; Jindal DP; Bansal R
    Acta Pharm; 2008 Dec; 58(4):393-405. PubMed ID: 19103574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyridazine derivatives XIV. Study of the vasorelaxant action of 6-aryl-5-piperidino-3-hydrazinopyridazines in isolated rat thoracic aorta: comparison with hydralazine.
    Campos-Toimil M; Estévez I; Raviña E; Orallo F
    Gen Pharmacol; 1998 Feb; 30(2):201-7. PubMed ID: 9580127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyridazinone derivatives: design, synthesis, and in vitro vasorelaxant activity.
    Abouzid K; Abdel Hakeem M; Khalil O; Maklad Y
    Bioorg Med Chem; 2008 Jan; 16(1):382-9. PubMed ID: 17905589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, biological evaluation and structure-activity relationships of new phthalazinedione derivatives with vasorelaxant activity.
    Munín J; Quezada E; Cuiñas A; Campos-Toimil M; Uriarte E; Santana L; Viña D
    Eur J Med Chem; 2014 Jul; 82():407-17. PubMed ID: 24929291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological activity of n-butylphthalide derivatives.
    Wang W; Cha XX; Reiner J; Gao Y; Qiao HL; Shen JX; Chang JB
    Eur J Med Chem; 2010 May; 45(5):1941-6. PubMed ID: 20133025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on agents with vasodilator and beta-blocking activities. IV.
    Seki T; Nakao T; Masuda T; Hasumi K; Gotanda K; Ishimori T; Honma S; Minami N; Shibata K; Yasuda K
    Chem Pharm Bull (Tokyo); 1996 Nov; 44(11):2061-9. PubMed ID: 8945771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An overview of pyridazin-3(2
    Abd-Rabo ZS; Serry AM; George RF
    Future Med Chem; 2024 Aug; 16(16):1685-1703. PubMed ID: 39105606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and vasorelaxant activity of 4-(cyclic amido)-2H-naphtho[1,2-b]pyrans.
    Chiou WF; Li SY; Ho LK; Hsien ML; Don MJ
    Eur J Med Chem; 2002 Jan; 37(1):69-75. PubMed ID: 11841876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of SVM-based classification model, synthesis and evaluation of prenylated flavonoids as vasorelaxant agents.
    Dong X; Liu Y; Yan J; Jiang C; Chen J; Liu T; Hu Y
    Bioorg Med Chem; 2008 Sep; 16(17):8151-60. PubMed ID: 18678502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro study and structure-activity relationship analysis of stilbenoid derivatives as powerful vasorelaxants: Discovery of new lead compound.
    Chan SY; Loh YC; Oo CW; Yam MF
    Bioorg Chem; 2020 Nov; 104():104239. PubMed ID: 33142420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and vasorelaxant evaluation of novel 7-methoxyl-2,3-disubstituted-quinoxaline derivatives.
    Zheng CB; Gao WC; Pang PP; Ma X; Peng LC; Yang L; Li X
    Bioorg Med Chem Lett; 2021 Mar; 36():127785. PubMed ID: 33444740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and synthesis of a series of combined vasodilator/beta-adrenoceptor antagonists based on 6-arylpyridazinones.
    Slater RA; Howson W; Swayne GT; Taylor EM; Reavill DR
    J Med Chem; 1988 Feb; 31(2):345-51. PubMed ID: 2892934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and selective coronary vasodilatory activity of 3,4-dihydro-2,2-bis(methoxymethyl)-2H-1-benzopyran-3-ol derivatives: novel potassium channel openers.
    Cho H; Katoh S; Sayama S; Murakami K; Nakanishi H; Kajimoto Y; Ueno H; Kawasaki H; Aisaka K; Uchida I
    J Med Chem; 1996 Sep; 39(19):3797-805. PubMed ID: 8809167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solid-phase synthesis and evaluation of libraries of substituted 4,5-dihydropyridazinones as vasodilator agents.
    Gouault N; Martin-Chouly CA; Lugnier C; Cupif JF; Tonnelier A; Feger F; Lagente V; David M
    J Pharm Pharmacol; 2004 Aug; 56(8):1029-37. PubMed ID: 15285848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imidazo[1,5-a]pyrimidine and benzo[4,5]imidazo-[1,2-a]pyrimidine derivatives as calcium antagonists.
    Alajarin R; Vaquero JJ; Alvarez-Builla J; de Casa-Juana MF; Sunkel C; Priego JG; Gomez-Sal P; Torres R
    Bioorg Med Chem; 1994 May; 2(5):323-9. PubMed ID: 7922143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.